|
|
Dr. Wolfgang Boomgaarden |
|
|
|
Herbert-Stiller-Award 2021 to Wolfgang Boomgaarden from biotech company PharmaInformatic: |
|
|
|
|
|
Because, as the association documents, less than 1% of public funding in Germany is still used for this future-oriented research, while 99% is wasted on animal experiments. "We know many active drugs from animal experiments or with in-vitro activity," adds Dr. Boomgaarden. "But they are not available on the market, because drug uptake in humans and animals often differs drastically and as a result they have failed in clinical trials in human."
|
|
Our research findings have shown, that not only ethical and scientific reasons speak against animal testing on drug-uptake. There is a strong commercial interest NOT to trust in results from animal drug-uptake. We found large differences in drug-uptake between animals and humans, which can mislead the development of future drugs, see current blockbuster-drugs with annual sales of at least $5 billion. |
|
|
|
|
|
|
|
|
|
Dr. Wolfgang Boomgaarden talked about the replacement of animal tests in drug discovery and development and about the economic & financial advantages if researchers do not carry out and rely on vague animal test results. |
|
|
|
© Copyright 2004-2021 PharmaInformatic Boomgaarden. All rights reserved. Site map Contact Terms of Use Imprint |
WE DO
RESEARCH
TO
REPLACE ANIMAL TESTS
Life Science Day 2016:
How
Artificial Intelligence
replaces
ANIMAL TESTING:
Deutsche
Biotechnologietage 2017
Künstliche Intelligenz
ersetzt Tierversuche:
Wirkstoff-Optimierung
mit
IMPACT-F